Ceretype Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 7

Ceretype General Information

Description

Developer of a brain imaging technology designed to revolutionize neuropsychiatric healthcare. The company's technology helps to improve drug discovery and patient care through its ability to subtype and classify the human brain on a neurobiological level and offers therapeutic strategies to address psychiatric illness and central nervous system disorders, enabling medical professionals to pioneer precision psychiatry.

Contact Information

Formerly Known As
Compass Neurosciences
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 Broadway
  • 14th Floor
  • Cambridge, MA 02142
  • United States
+1 (917)
Primary Industry
Decision/Risk Analysis
Corporate Office
  • 1 Broadway
  • 14th Floor
  • Cambridge, MA 02142
  • United States
+1 (917)

Ceretype Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ceretype Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 18-Mar-2026 Completed Generating Revenue
4. Later Stage VC 29-Sep-2025 Completed Generating Revenue
3. Early Stage VC 11-Jul-2024 Completed Generating Revenue
2. Accelerator/Incubator 27-Feb-2023 $100K $2.3M Completed Generating Revenue
1. Seed Round 24-Oct-2021 $2.2M $2.2M Completed Generating Revenue
To view Ceretype’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Ceretype Patents

Ceretype Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024381209-A1 Autocalibrating multi-echo functional magnetic resonance imaging Pending 15-Nov-2023
EP-4809313-A1 Autocalibrating multi-echo functional magnetic resonance imaging Pending 15-Nov-2023
WO-2025106746-A1 Autocalibrating multi-echo functional magnetic resonance imaging Inactive 15-Nov-2023
EP-4712848-A2 Multi-echo fmri reports Pending 19-May-2023
US-20260321373-A1 Multi-echo fmri reports Pending 19-May-2023 G16H15/00
To view Ceretype’s complete patent history, request access »

Ceretype Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ceretype Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cedar Street Group Venture Capital Minority
One Mind Accelerator/Incubator Minority
Catalytic Impact Foundation Not-For-Profit Venture Capital Minority
Impact Assets Impact Investing Minority
JLS Fund Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ceretype FAQs

  • When was Ceretype founded?

    Ceretype was founded in 2020.

  • Where is Ceretype headquartered?

    Ceretype is headquartered in Cambridge, MA.

  • What is the size of Ceretype?

    Ceretype has 6 total employees.

  • What industry is Ceretype in?

    Ceretype’s primary industry is Decision/Risk Analysis.

  • Is Ceretype a private or public company?

    Ceretype is a Private company.

  • What is Ceretype’s current revenue?

    The current revenue for Ceretype is .

  • How much funding has Ceretype raised over time?

    Ceretype has raised $2.7M.

  • Who are Ceretype’s investors?

    Cedar Street Group, One Mind, Catalytic Impact Foundation, Impact Assets, and JLS Fund are 5 of 7 investors who have invested in Ceretype.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process